PM indications before and after TAVI

Size: px
Start display at page:

Download "PM indications before and after TAVI"

Transcription

1 PM indications before and after TAVI PD Dr. med. Stefan Toggweiler LA Herzzentrum Leiter interventionelle Klappentherapie Luzerner Kantonsspital 6000 Luzern

2 Agenda Basics Predictors for PPM implantation Is the ECG post TAVI a better predictor? Does complete heart block or PM dependency resolve? Prognostic relevance of PPM PM indications

3 PM after TAVI and SAVR: PARTNER A Smith et al., NEJM 2011

4 PARTNER and PARTNER registry Randomized cohort: 5.6% Non-randomized registry: 9.6% Overall: 8.8%

5 PM after SAVR and TAVI (matched) Bagur et al., JACC Intv 2012

6 PPM rates in Switzerland Wenaweser et al., EuroIntervention 2014

7 Anatomy: Conduction system and valve

8 LBBB occurs before RBBB Pooled data from USZ and LUKS

9 Anatomy: conduction system and cusps

10 Implantation height: measure between RC and NC cusp NCC RCC LCC

11 Amount of septal compression Nazif et al., JACC Intv 2015

12 PPM and Sapien 3 Pooled data from USZ and LUKS 9.4% 17.9%

13 PPM and Sapien 3

14 Predictors for a new PPM Predictor OR RBBB Oversizing 4.1 CoreValve use Bradycardia / AVB LAHB Prior radiation of chest 2.3 Age > 80 years 1.4 Prosthesis/LVOT diameter per Implantation depth per mm Male sex 1.2 LV-EDD, per cm.76 LVOT diameter per mm.37 Porcelain aorta / Calcification Nazif et al., JACC Intv 2015 Lewdoch et al, CCI 2013 Bagur et al., JACC Intv 2012 Bleiziffer et al., JACC Intv 2010 Baan et al., Am Heart J 2010 Sinhal et al., JACC Intv 2008 Van der Boon et al., CCI 2015 Siontis et al, JACC 2014 Boerlage et al, PACE 2014 Tchetche et al., EuroInterv 2012

15 The prognostic value of the ECG post TAVI: Need for a PPM No difference between CV and SAPIEN XT/3 Pooled data from USZ and LUKS

16 Timing of complete heart block Pooled data from USZ and LUKS

17 The problem of late heart blocks Day Valve ECG at ECG post TAVI baseline 1 CoreValve Normal ECG LBBB 1 SAPIEN XT Normal ECG LBBB 1 CoreValve LBBB LBBB 1 SAPIEN 3 LBBB LBBB + AVB 1 2 CoreValve RBBB RBBB 2 CoreValve Normal ECG LBBB 2 CoreValve LBBB LBBB 2 SAPIEN 3 RBBB RBBB 2 CoreValve Normal ECG LBBB + AVB 1 3 CoreValve AVB 1 LBBB + AVB 1 3 SAPIEN 3 Normal AVB 1 3 SAPIEN 3 RBBB RBBB + AVB 1 4 CoreValve Normal LBBB + AVB 1 5 SAPIEN 3 LBBB LBBB + AVB 1 Pooled data from USZ and LUKS

18 The problem of very late heart blocks Valve Day 1 Day 2 Day 3 Day 4 Day 5 CoreValve AVB II SAPIEN AVB II SAPIEN AVB II CoreValve AVB II SAPIEN AVB III Pooled data from USZ and LUKS

19 ECG post TAVI: summary Predictor for heart block and need for PPM, valid for Medtronic CV and Sapien XT/3 Normal postprocedural ECG: No heart blocks, no need for PPM Very late heart blocks occur in those with first degree AVB (or bradicardia, if afib), PQ gradually increases Manuscript in preparation

20 Recommended duration of telemetry monitoring Manuscript in preparation

21 Very late heart block with bradycardia (CE-mark study self expanding valve) Baseline: Afib, bradycardia, HR 53/min, asymptomatic Post TAVI: New LBBB, Afib, bradycardia, HR 40-60/min, asymptomatic 7 days after TAVI Syncope at home CHB PM implantation

22 Do conduction disorders resolve? Houthuizen et al., EuroIntervention 2014

23 Do conduction disorders resolve? Houthuizen et al., EuroIntervention 2014

24 Pacemaker dependency during followup Median follow-up of 11.5 months Van der Boon et al., Int J Cardiol 2014

25 Evolution of VP and AP Most patients paced > 10% of time

26 Prognostic relevance of new PPM Buellesfeld et al., JACC 2012

27 Prognostic relevance: PARTNER data Nazif et al., JACC Intv 2015

28 Effect on LV-EF Data from LUKS

29 Indication for PPM after TAVI o Complete AV block o o o o o o o o Usually PM indication Consider watchful waiting if balloon expandable valve was implanted First degree AV block and narrow QRS Watchful waiting, daily ECG. PM if PQ continues to increase First degree AV block and wide QRS (LSB) Watchful waiting if PQ < 250 ms. PM indication more liberal Afib with bradycardia or sinus bradycardia Only watchful waiting if HR > 50/min and asymptomatic, monitor for 5 days

30 Indication for PPM before TAVI: personal recommendations Recommended: any symptomatic bradycardia or higher degree AVB Consider: RBBB or LBBB and AVB 1 or bradycardia (afib, SB) < 60/min May consider: RBBB and planned intervention with a selfexpanding valve or big valve in small LVOT

31 Think about CRT! Any patient requiring a permanent PM and LV-EF < 45%

32 Apparently + =

Pacemaker After Transcatheter Aortic Valve Implantation: Where, When and How?

Pacemaker After Transcatheter Aortic Valve Implantation: Where, When and How? Pacemaker After Transcatheter Aortic Valve Implantation: Where, When and How? Michael Glikson, MD, FESC, FACC Davidai Arrhythmia Center, Israel Europace 2011 Conflict of Interest Research grants from device

More information

Pacemaker rates Second generation TAVI Devices

Pacemaker rates Second generation TAVI Devices Pacemaker rates Second generation TAVI Devices Florian Krackhardt, M.D. Department of Cardiology Charité Campus Virchow-Klinikum University Hospital Berlin, Germany TAVI The future s looking very positive

More information

Is TAVI ready for prime time in: - Intermediate risk patients? - Low risk patients?

Is TAVI ready for prime time in: - Intermediate risk patients? - Low risk patients? Is TAVI ready for prime time in: - Intermediate risk patients? - Low risk patients? Didier TCHETCHE, MD. Clinique PASTEUR, Toulouse, France, Conflicts of interest: -Consultant for Edwards LifeSciences

More information

Pacemaker implantation after transcatheter aortic valve: why is this still happening?

Pacemaker implantation after transcatheter aortic valve: why is this still happening? Review Article Pacemaker implantation after transcatheter aortic valve: why is this still happening? Stefan Toggweiler, Richard Kobza Heart Center Lucerne, Luzerner Kantonsspital, Lucerne, Switzerland

More information

Complications after TAVI: VARC Definitions, Frequency and Management Considerations Patrick W. Serruys, Nicolo Piazza,

Complications after TAVI: VARC Definitions, Frequency and Management Considerations Patrick W. Serruys, Nicolo Piazza, Complications after TAVI: VARC Definitions, Frequency and Management Considerations Patrick W. Serruys, Nicolo Piazza, Nicolas M. Van Mieghem, Yoshinobu Onuma, Martin B. Leon TCT-AP 2011 April 27 th, 2011

More information

Andrzej Ochala, MD Medical University of Silesia, Katowice, Poland

Andrzej Ochala, MD Medical University of Silesia, Katowice, Poland Andrzej Ochala, MD Medical University of Silesia, Katowice, Poland Bicuspid aortic valve o Most common congenital heart disease in adults (1% - 2%) o AS is the most common complication of BAV o Patophysiology

More information

TAVI Technology and Procedural Changes

TAVI Technology and Procedural Changes TCT AP 2013 Seoul, South Korea April, 2013 TAVI Technology and Procedural Changes Eberhard Grube MD, FACC, FSCAI University Hospital, Dept of Medicine II, Bonn, Germany Hospital Alemão Oswaldo Cruz, São

More information

TAVR: Review of the Robust Data from Randomized Trials

TAVR: Review of the Robust Data from Randomized Trials TAVR: Review of the Robust Data from Randomized Trials Nicholas J. Ruggiero II, MD,FACP, FACC, FSCAI, FSVM, FCPP Director, Structural Heart Disease and Non-Coronary Interventions Director, Jefferson Heart

More information

TAVR for low-risk patients in 2017: not so fast.

TAVR for low-risk patients in 2017: not so fast. TAVR for low-risk patients in 2017: not so fast. Enrico Ferrari, MD, FETCS Cardiac Surgery Department Cardiocentro Ticino Foundation Lugano, Switzerland Conflicts of Interest Consultant and proctor for

More information

TAVI in Korea, How to Avoid Conduction

TAVI in Korea, How to Avoid Conduction TAVI in Korea, How to Avoid Conduction Disturbance after CoreValve Seung-Jung Park, MD, PhD Professor of Medicine, University of Ulsan College of Medicine, Heart Institute, Asan Medical Center, Seoul,

More information

Transcatheter Aortic Valve Implantation (TAVI) - 5 important lessons learnt from HK experiences Michael KY Lee

Transcatheter Aortic Valve Implantation (TAVI) - 5 important lessons learnt from HK experiences Michael KY Lee Transcatheter Aortic Valve Implantation (TAVI) - 5 important lessons learnt from HK experiences Michael KY Lee Queen Elizabeth Hospital, Hong Kong President, HKSTENT APCASH 2013 SJ Park TAVI Summit 2013

More information

TAVI limitations for low risk patients

TAVI limitations for low risk patients TAVI limitations for low risk patients Dr. T. Modine / P. Lancellotti MD, PhD, MBA CHRU de Lille, France Potential conflicts of interest Speaker's name: Thomas Modine I have the following potential conflicts

More information

Incidence And Predictors Of Left Bundle Branch Block After Transcatheter Aortic Valve Implantation

Incidence And Predictors Of Left Bundle Branch Block After Transcatheter Aortic Valve Implantation Incidence And Predictors Of Left Bundle Branch Block After Transcatheter Aortic Valve Implantation Ömer Aktug 1, MD; Guido Dohmen 2, MD; Kathrin Brehmer 1, MD; Verena Deserno 1 ; Ralf Herpertz 1 ; Rüdiger

More information

Aortic Stenosis and TAVR TARUN NAGRANI, MD INTERVENTIONAL AND ENDOVASCULAR CARDIOLOGIST, SOMC

Aortic Stenosis and TAVR TARUN NAGRANI, MD INTERVENTIONAL AND ENDOVASCULAR CARDIOLOGIST, SOMC Aortic Stenosis and TAVR TARUN NAGRANI, MD INTERVENTIONAL AND ENDOVASCULAR CARDIOLOGIST, SOMC No Financial Disclosures Aortic Stenosis AS is an insidious disease with a long latency period followed by

More information

Transcatheter Aortic Valve Replacement

Transcatheter Aortic Valve Replacement Transcatheter Aortic Valve Replacement Jesse Jorgensen, MD Medical Director, Cardiac Catheterization Laboratory Greenville Health System Greenville, South Carolina, USA January 30, 2016 Aortic Stenosis

More information

Edwards Sapien. Medtronic CoreValve. Inoperable FDA approved High risk: in trials. FDA approved

Edwards Sapien. Medtronic CoreValve. Inoperable FDA approved High risk: in trials. FDA approved Transcatheter Aortic Valve Replacement Symptomatic Aortic Stenosis Asymptomatic Juan Crestanello, MD Interim Director, Division of Cardiac Surgery Associate Professor Division of Cardiac Surgery The Ohio

More information

A review of the complications associated with Transcatheter Aortic Valve Implantation.

A review of the complications associated with Transcatheter Aortic Valve Implantation. A review of the complications associated with Transcatheter Aortic Valve Implantation. Dr Conor McQuillan Transcatheter Aortic Valve Implantation (TAVI) has become the standard of care for treating elderly,

More information

CRITERIA LIST/ QUALIFICATIONS:

CRITERIA LIST/ QUALIFICATIONS: TRANSCEND CONDITION: Coronary Artery Disease PI: Peter Alden, MD CONTACT INFO: JoAnne Goldman joanne.goldman@allina.com 612-863-3973 DESCRIPTION: To demonstrate that the SurVeil DCB is non-inferior to

More information

Strokes After TAVR. Ioannis Iakovou, MD, PhD. Interventional Cardiology Onassis Cardiac Surgery Center

Strokes After TAVR. Ioannis Iakovou, MD, PhD. Interventional Cardiology Onassis Cardiac Surgery Center Strokes After TAVR Ioannis Iakovou, MD, PhD Interventional Cardiology Onassis Cardiac Surgery Center Strokes After TAVR How common is stroke after TAVR Is it increasing? Is it more with TF vs TA? Is it

More information

His Bundle Pacing: Where is it going? Kenneth A. Ellenbogen, M.D. Kontos Professor, VCU School of Medicine November 17, 2017

His Bundle Pacing: Where is it going? Kenneth A. Ellenbogen, M.D. Kontos Professor, VCU School of Medicine November 17, 2017 His Bundle Pacing: Where is it going? Kenneth A. Ellenbogen, M.D. Kontos Professor, VCU School of Medicine November 17, 2017 Conflicts Medtronic: Research, Honoraria, Consulting Boston Scientific: Research,

More information

Current Evidence in TAVI patients using ACURATE and LOTUS valves

Current Evidence in TAVI patients using ACURATE and LOTUS valves Current Evidence in TAVI patients using ACURATE and LOTUS valves Giuseppe Tarantini, MD, PhD, FESC, Professor and Director of Interventional Cardiology University of Padua GISE President Potential conflicts

More information

A Thoughtful Synthesis of the TAVR Landscape: What s New, What s Needed and is There a Best-in-Class?

A Thoughtful Synthesis of the TAVR Landscape: What s New, What s Needed and is There a Best-in-Class? TVT Chicago Thursday 16th of June 2016 Session 1: TAVR 2016 Highlights and Controversies A Thoughtful Synthesis of the TAVR Landscape: What s New, What s Needed and is There a Best-in-Class? Ian T. Meredith

More information

The Future of Medicine. Who to TAVR? Azeem Latib MD EMO-GVM Centro Cuore Columbus and San Raffaele Scientific Institute, Milan, Italy

The Future of Medicine. Who to TAVR? Azeem Latib MD EMO-GVM Centro Cuore Columbus and San Raffaele Scientific Institute, Milan, Italy The Future of Medicine Who to TAVR? Azeem Latib MD EMO-GVM Centro Cuore Columbus and San Raffaele Scientific Institute, Milan, Italy FIRST PATIENT TO UNDERGO PTCA FIRST PATIENT TO UNDERGO TAVI Grüntzig

More information

Severe Aortic Valve Disease: TAVR in Four Ages and Four Etiologies Age 25 y/o Congenital, 50 y/o Bicuspid, 75 y/o Rheumatic, 100 y/o Degenerative

Severe Aortic Valve Disease: TAVR in Four Ages and Four Etiologies Age 25 y/o Congenital, 50 y/o Bicuspid, 75 y/o Rheumatic, 100 y/o Degenerative Severe Aortic Valve Disease: TAVR in Four Ages and Four Etiologies Age 25 y/o Congenital, 50 y/o Bicuspid, 75 y/o Rheumatic, 100 y/o Degenerative Samin K. Sharma, MD, FACC, FSCAI Director Clinical & Interventional

More information

New York Valves Patient focused evidence-based approach. New York City: 6 December Antonio Colombo

New York Valves Patient focused evidence-based approach. New York City: 6 December Antonio Colombo New York Valves 2018 Patient focused evidence-based approach New York City: 6 December 2018 Antonio Colombo Speaker 7 EMO GVM Centro Cuore Columbus Milan, Italy No conflicts to report Vascular complications

More information

Conduction abnormalities after transcatheter aortic valve implantation

Conduction abnormalities after transcatheter aortic valve implantation Journal of Geriatric Cardiology (2018) 15: 105 112 2018 JGC All rights reserved; www.jgc301.com Review Open Access Conduction abnormalities after transcatheter aortic valve implantation Panagiotis Karyofillis,

More information

Incorporating the intermediate risk in Transcatheter Aortic Valve Implantation (TAVI)

Incorporating the intermediate risk in Transcatheter Aortic Valve Implantation (TAVI) Incorporating the intermediate risk in Transcatheter Aortic Valve Implantation (TAVI) Larry S. Dean, MD, MSCAI Past President SCAI Professor of Medicine and Surgery University of Washington School of Medicine

More information

RANDOMISED TRIALS TAVI WITH SAVR STEPHAN WINDECKER AORTIC VALVE DISEASE COMPARING

RANDOMISED TRIALS TAVI WITH SAVR STEPHAN WINDECKER AORTIC VALVE DISEASE COMPARING AORTIC VALVE DISEASE RANDOMISED TRIALS COMPARING TAVI WITH SAVR STEPHAN WINDECKER DEPARTMENT OF CARDIOLOGY SWISS CARDIOVASCULAR CENTER AND CLINICAL TRIALS UNIT BERN BERN UNIVERSITY HOSPITAL, SWITZERLAND

More information

Le TAVI pour tout le monde?

Le TAVI pour tout le monde? Le TAVI pour tout le monde? Thierry Lefèvre Institut Cardiovasculaire Paris Sud, Massy Disclosure Statement of Financial Interest I currently have, or have had over the last two years, an affiliation or

More information

TAVR-Update Andrzej Boguszewski MD, FACC, FSCAI Vice Chairman, Cardiology Mid-Michigan Health Associate Professor Michigan State University, Central

TAVR-Update Andrzej Boguszewski MD, FACC, FSCAI Vice Chairman, Cardiology Mid-Michigan Health Associate Professor Michigan State University, Central TAVR-Update Andrzej Boguszewski MD, FACC, FSCAI Vice Chairman, Cardiology Mid-Michigan Health Associate Professor Michigan State University, Central Michigan University 1 Disclosure Chiesi Pharma- Consultant

More information

Clinical and hemodynamic effects of transcatheter aortic valve implantation Yong, Z.Y.

Clinical and hemodynamic effects of transcatheter aortic valve implantation Yong, Z.Y. UvA-DARE (Digital Academic Repository) Clinical and hemodynamic effects of transcatheter aortic valve implantation Yong, Z.Y. Link to publication Citation for published version (APA): Yong, Z. Y. (2012).

More information

(EU), FACC (USA), FSCAI (USA)

(EU), FACC (USA), FSCAI (USA) How to reduce vascular complications of TAVI Paul TL Chiam MBBS (S pore), MMed, MRCP (UK), FAMS FRCP (Edin), FESC (EU), FACC (USA), FSCAI (USA) Cardiologist Mount Elizabeth Hospital Singapore Definition

More information

TAVR SPRING 2017 The evolution of TAVR

TAVR SPRING 2017 The evolution of TAVR TAVR SPRING 2017 The evolution of TAVR Matthew Johnson, MD Disclosers None Evolution of the Balloon- Expandable Transcatheter Valves Cribier 2002 SAPIEN 2006 SAPIEN XT 2009 SAPIEN 3 2013 * Sheath compatibility

More information

Transcatheter aortic valves in aortic regurgitation Gry Dahle Dept of Cardiothoracic- and vascular surgery Rikshospitalet, Oslo University Hospital,

Transcatheter aortic valves in aortic regurgitation Gry Dahle Dept of Cardiothoracic- and vascular surgery Rikshospitalet, Oslo University Hospital, Transcatheter aortic valves in aortic regurgitation Gry Dahle Dept of Cardiothoracic- and vascular surgery Rikshospitalet, Oslo University Hospital, Oslo, Norway Aortic regurgitation Prevalence in Framingham

More information

Trans Catheter Aortic Valve Replacement

Trans Catheter Aortic Valve Replacement Trans Catheter Aortic Valve Replacement Satish K Surabhi, MD,FACC,FSCAI Medical Director, Cardiac Cath Labs AnMed Health Heart and Vascular Care No financial conflict of interest related to this talk Will

More information

Transcatheter Aortic Valve Implantation. SSVQ November 23, 2012 Centre Mont-Royal 15:40

Transcatheter Aortic Valve Implantation. SSVQ November 23, 2012 Centre Mont-Royal 15:40 Transcatheter Aortic Valve Implantation SSVQ November 23, 2012 Centre Mont-Royal 15:40 Nicolo Piazza MD, PhD, FRCPC, FESC, FACC McGill University Health Center German Heart Center Munich 1 First-in-Human

More information

Structural Heart Disease Transcatheter Aortic Valve Replacement (TAVR)

Structural Heart Disease Transcatheter Aortic Valve Replacement (TAVR) Structural Heart Disease Transcatheter Aortic Valve Replacement (TAVR) Kathleen Harper DO FACC FACP 87 Chief, Cardiology Section VA Maine Healthcare Kathleen.Harper@va.gov Prevalence of Aortic Stenosis

More information

Dipartimento di Scienze Cardiovascolari Università Campus Bio-Medico di Roma Dott. Vito Calabrese

Dipartimento di Scienze Cardiovascolari Università Campus Bio-Medico di Roma Dott. Vito Calabrese Dipartimento di Scienze Cardiovascolari Università Campus Bio-Medico di Roma Dott. Vito Calabrese Because the primary objective was cure symptomatic bradicardya due to syncope Because this is the common

More information

Prof. Dr. Thomas Walther. TAVI in ascending aorta / aortic root dilatation

Prof. Dr. Thomas Walther. TAVI in ascending aorta / aortic root dilatation Prof. Dr. Thomas Walther TAVI in ascending aorta / aortic root dilatation nn AorticStenosis - Guidelines TAVI and aortic aneurysm? Few data published. EJCTS 2014;46:228-33 TAVI and aortic aneurysm? Few

More information

The Role of TAVI in high-risk and normal-risk Patients

The Role of TAVI in high-risk and normal-risk Patients The Role of TAVI in high-risk and normal-risk Patients Joachim Schofer Hamburg University Cardiovascular Center and Department for percutaneous treatment of structural heart disease Albertinen Heart Center

More information

Transcatheter Aortic Valve Implantation Present Status and Perspectives

Transcatheter Aortic Valve Implantation Present Status and Perspectives Transcatheter Aortic Valve Implantation Present Status and Perspectives Angioplasty Summit TCTAP 2010 Alain Cribier, MD University of Rouen, France Transcatheter Aortic Valve Implantation has entered the

More information

Introduction. Aims. Keywords transcatheter aortic valve implantation pacemaker calcium distribution simulation 3D printing

Introduction. Aims. Keywords transcatheter aortic valve implantation pacemaker calcium distribution simulation 3D printing European Heart Journal Cardiovascular Imaging (2016) 17, 1385 1393 doi:10.1093/ehjci/jev343 Calcium distribution patterns of the aortic valve as a risk factor for the need of permanent pacemaker implantation

More information

Hafþór Ingi Ragnarsson. Thesis for the Degree of Bachelor of Science University of Iceland Faculty of Medicine School of Health Sciences

Hafþór Ingi Ragnarsson. Thesis for the Degree of Bachelor of Science University of Iceland Faculty of Medicine School of Health Sciences Rates of and predictors for the need of permanent pacemaker and its long-term utilization in patients undergoing surgical or transcatheter aortic valve replacement Hafþór Ingi Ragnarsson Thesis for the

More information

Optimal Imaging Technique Prior to TAVI -Echocardiography-

Optimal Imaging Technique Prior to TAVI -Echocardiography- 2014 KSC meeting Optimal Imaging Technique Prior to TAVI -Echocardiography- Geu-Ru Hong, M.D. Ph D Associate Professor of Medicine Division of Cardiology, Severance Cardiovascular Hospital Yonsei University

More information

TAVR today: High Risk, Intermediate Risk Population, and Valve in Valve Therapy

TAVR today: High Risk, Intermediate Risk Population, and Valve in Valve Therapy TAVR today: High Risk, Intermediate Risk Population, and Valve in Valve Therapy Alan Zajarias, MD FACC Structural Interventional Fellowship Director Associate Professor Medicine Cardiovascular Division

More information

Current Controversies. Subclinical and clinical valve thrombosis

Current Controversies. Subclinical and clinical valve thrombosis Chapter 19: Current controversies, ongoing trials, new valves, and future directions Sukhdeep S. Basra, MD, MPH, Michael J. Mack, MD The Heart Hospital Baylor Plano, Texas Transcatheter Aortic Valve Replacement

More information

How to manage TAVI related vascular complications. Paul TL Chiam MBBS, FRCP, FESC, FACC, FSCAI

How to manage TAVI related vascular complications. Paul TL Chiam MBBS, FRCP, FESC, FACC, FSCAI How to manage TAVI related vascular complications Paul TL Chiam MBBS, FRCP, FESC, FACC, FSCAI Definition VARC-2 consensus statement Complications caused by: Wire Catheter Anything related to vascular access

More information

After PARTNER 2A/S3i and SURTAVI: What is the Role of Surgery in Intermediate-Risk AS Patients?

After PARTNER 2A/S3i and SURTAVI: What is the Role of Surgery in Intermediate-Risk AS Patients? After PARTNER 2A/S3i and SURTAVI: What is the Role of Surgery in Intermediate-Risk AS Patients? Vinod H. Thourani, MD Professor of Surgery and Medicine Emory University Disclosure Statement of Financial

More information

Cardiac Resynchronization Therapy Guidelines and Missing Groups

Cardiac Resynchronization Therapy Guidelines and Missing Groups Cardiac Resynchronization Therapy Guidelines and Missing Groups Frank Pelosi, Jr., MD, FACC, FHRS Director, Cardiac Electrophysiology Fellowship Associate Professor of Medicine University of Michigan Health

More information

Valve Replacement without a Scalpel Transcatheter Aortic Valve Replacement (TAVR) Charles T. Klodell, M.D.

Valve Replacement without a Scalpel Transcatheter Aortic Valve Replacement (TAVR) Charles T. Klodell, M.D. Valve Replacement without a Scalpel Transcatheter Aortic Valve Replacement (TAVR) Charles T. Klodell, M.D. Professor, Thoracic and Cardiovascular Surgery University of Florida klodell@surgery.ufl.edu Disclosures

More information

Transcatheter Valve Replacement: Current State in 2017

Transcatheter Valve Replacement: Current State in 2017 Transcatheter Valve Replacement: Current State in 2017 Marc A. Sintek MD Assistant Professor of Medicine Interventional Cardiology Cardiovascular Division Washington University in St. Louis Missouri ACP

More information

Assessment and Preparation of Patients with TAVI. Rob Tanzola Associate Professor, Queen s University

Assessment and Preparation of Patients with TAVI. Rob Tanzola Associate Professor, Queen s University Assessment and Preparation of Patients with TAVI Rob Tanzola Associate Professor, Queen s University My patient has aortic stenosis and needs non-cardiac surgery Should (s)he get a TAVI? Rob Tanzola Associate

More information

Potential conflicts of interest

Potential conflicts of interest Potential conflicts of interest Speaker's name: Petros Dardas MEDTRONIC proctor for TAVI Intermediate risk 83 FEMALE COAD SEVERE AS NYHA III Mean gradient 35 mmhg, AVA 0.45cm2, SVI 21ml/m2 Paradoxical

More information

CRT: whom does it benefit?

CRT: whom does it benefit? CRT: whom does it benefit? Francisco Leyva BSH Revalidation and Training 2018 Queen Elizabeth Hospital NICE guidelines for CRT LVEF 35% NYHA class I II III IV QRS

More information

CIPG Transcatheter Aortic Valve Replacement- When Is Less, More?

CIPG Transcatheter Aortic Valve Replacement- When Is Less, More? CIPG 2013 Transcatheter Aortic Valve Replacement- When Is Less, More? James D. Rossen, M.D. Professor of Medicine and Neurosurgery Director, Cardiac Catheterization Laboratory and Interventional Cardiology

More information

How Do I Balance Bradycardia with Rate Control in Atrial Fibrillation?

How Do I Balance Bradycardia with Rate Control in Atrial Fibrillation? How Do I Balance Bradycardia with Rate Control in Atrial Fibrillation? Thang Nguyen MD FRCPC Assistant Professor Section of Cardiology Department of Internal Medicine University of Manitoba Objectives

More information

What the Cardiologist needs to know from Medical Images

What the Cardiologist needs to know from Medical Images What the Cardiologist needs to know from Medical Images Gerald Maurer Department of Cardiology Medical University of Vienna What kinds of Cardiologists Plumbers Electricians Photographers And then there

More information

Dr. Jean-Claude Laborde

Dr. Jean-Claude Laborde Medtronic CoreValve Experience Alternative Access (Subclavian) and Technology Evolution of the Medtronic CoreValve TAVI System Dr. Jean-Claude Laborde Glenfield Hospital, Leicester, U.K. St George Hospital,

More information

Ongoing requirement for pacing post-transcatheter aortic valve implantation and surgical aortic valve replacement

Ongoing requirement for pacing post-transcatheter aortic valve implantation and surgical aortic valve replacement Interactive CardioVascular and Thoracic Surgery 17 (2013) 328 333 doi:10.1093/icvts/ivt175 Advance Access publication 25 April 2013 ORIGINAL ARTICLE ADULT CARDIAC Ongoing requirement for pacing post-transcatheter

More information

Mild paravalvular regurgitation is not an independent predictor of mortality following TAVI

Mild paravalvular regurgitation is not an independent predictor of mortality following TAVI Mild paravalvular regurgitation is not an independent predictor of mortality following TAVI Philippe Pibarot, DVM, PhD, FACC, FAHA, FASE Canada Research Chair in Valvular Heart Diseases INSTITUT UNIVERSITAIRE

More information

Igor Palacios, MD Director of Interventional Cardiology Massachusetts General Hospital Professor of Medicine Harvard Medical School

Igor Palacios, MD Director of Interventional Cardiology Massachusetts General Hospital Professor of Medicine Harvard Medical School Aortic Stenosis: Current State of Percutaneous Therapies, Emerging Technologies and Future Directions Igor Palacios, MD Director of Interventional Cardiology Massachusetts General Hospital Professor of

More information

Complicanze durante TAVI. Brambilla Nedy IRCCS Policlinico San Donato

Complicanze durante TAVI. Brambilla Nedy IRCCS Policlinico San Donato Complicanze durante TAVI Brambilla Nedy IRCCS Policlinico San Donato 0 2 4 6 9 11 14 16 22 26 31 33 37 43 52 61 69 78 87 93 106 113 121 151 171 186 201 225 267 283 294 311 349 502 515 709 1007 Number of

More information

Imaging in TAVI. Jeroen J Bax Dept of Cardiology Leiden Univ Medical Center The Netherlands Davos, feb 2013

Imaging in TAVI. Jeroen J Bax Dept of Cardiology Leiden Univ Medical Center The Netherlands Davos, feb 2013 Imaging in TAVI Jeroen J Bax Dept of Cardiology Leiden Univ Medical Center The Netherlands Davos, feb 2013 Research grants: Medtronic, Biotronik, Boston Scientific, St Jude, BMS imaging, GE Healthcare,

More information

2/28/2010. Speakers s name: Paul Chiam. I have the following potential conflicts of interest to report: NONE. Antegrade transvenous transseptal route

2/28/2010. Speakers s name: Paul Chiam. I have the following potential conflicts of interest to report: NONE. Antegrade transvenous transseptal route Transcatheter Aortic Valve Implantation Asian perspective Speakers s name: Paul Chiam Paul TL Chiam MBBS, MRCP, FACC I have the following potential conflicts of interest to report: NONE Consultant National

More information

Cardiac Resynchronisation Therapy for all Patients Requiring Ventricular Pacing

Cardiac Resynchronisation Therapy for all Patients Requiring Ventricular Pacing Cardiac Resynchronisation Therapy for all Patients Requiring Ventricular Pacing Philippe Mabo University Hospital, Rennes, France ESC Congress 2010, Stockholm 29 Aug 2010 Which Patients? Candidate for

More information

How to Prevent Thromboembolic Complications in TAVI

How to Prevent Thromboembolic Complications in TAVI How to Prevent Thromboembolic Complications in TAVI PETER WENAWESER, MD Swiss Cardiovascular Centre, University Hospital, Bern, Switzerland Potential Conflicts of Interest Proctoring and lecture fees from

More information

Extension to medium and low risk patients? Friedrich Eckstein University Hospital Basel

Extension to medium and low risk patients? Friedrich Eckstein University Hospital Basel TAVI CON Extension to medium and low risk patients? Friedrich Eckstein University Hospital Basel Extension to medium and low risk patients? In octogenerians already reality in most of the swiss clinics!?

More information

TAVR in 2017 What we know? What to expect?

TAVR in 2017 What we know? What to expect? Journal of Geriatric Cardiology (2018) 15: 55 60 2018 JGC All rights reserved; www.jgc301.com Perspective Open Access TAVR in 2017 What we know? What to expect? Panagiota Kourkoveli 1,*, Konstantinos Spargias

More information

History. 2D echo before TAVI. 88 female Hypertensive - hyperlipidemic History of LOC syncope Echo: severe AS AV gradient 90 mmhg Good LV LVH

History. 2D echo before TAVI. 88 female Hypertensive - hyperlipidemic History of LOC syncope Echo: severe AS AV gradient 90 mmhg Good LV LVH History 88 female Hypertensive - hyperlipidemic History of LOC syncope Echo: severe AS AV gradient 90 mmhg Good LV LVH 2D echo before TAVI LHC: Normal cors Pre severe calcification LVOT calcification

More information

Treatment of Bio-Prosthetic Valve Deterioration Using Transcatheter Techniques

Treatment of Bio-Prosthetic Valve Deterioration Using Transcatheter Techniques Treatment of Bio-Prosthetic Valve Deterioration Using Transcatheter Techniques Pablo Codner, Abid Assali, Hanna Vaknin-Assa, Katia Orvin, Ram Sharony, Leor Perl, Gabriel Greenberg, Marina Kupershmidt,

More information

TAVI: Transapical Procedures

TAVI: Transapical Procedures Cardiology Update Davos TAVI: Transapical Procedures Volkmar Falk, MD University Hospital Zürich TA-AVI: antegrade, simple, safe The front door approach! Transapical TAVI Technical advantages of TA approach

More information

TAVI IN BICUSPID AOV AND VALVE-IN-VALVE

TAVI IN BICUSPID AOV AND VALVE-IN-VALVE TAVI IN BICUSPID AOV AND VALVE-IN-VALVE Petros S. Dardas, MD, FESC St Lukes Hospital Thessaloniki, GREECE 6o ΣΥΝΕΔΡΙΟ ΔΙΑΚΑΘΕΤΗΡΙΑΚΗΣ ΘΕΡΑΠΕΙΑΣ ΚΑΡΔΙΑΚΩΝ ΒΑΛΒΙΔΟΠΑΘΕΙΩΝ ΑΘΗΝΑ 2017 BICUSPID AOV Surgical

More information

New Developments in Cardiac Intervention. Dr Elaine Chau HK Sanatorium & Hospital, Hong Kong 17 January 2016

New Developments in Cardiac Intervention. Dr Elaine Chau HK Sanatorium & Hospital, Hong Kong 17 January 2016 New Developments in Cardiac Intervention Dr Elaine Chau HK Sanatorium & Hospital, Hong Kong 17 January 2016 Cardiac Intervention Coronary intervention BVS Valvular heart disease TAVI, Mitraclips Ventricular

More information

Permanent pacemaker insertion in patients with conduction abnormalities post transcatheter aortic valve replacement: a review and proposed guidelines

Permanent pacemaker insertion in patients with conduction abnormalities post transcatheter aortic valve replacement: a review and proposed guidelines Review Article Page 1 of 8 Permanent pacemaker insertion in patients with conduction abnormalities post transcatheter aortic valve replacement: a review and proposed guidelines Tamunoinemi Bob-Manuel 1

More information

ΔΙΑΔΕΡΜΙΚΗ ΑΝΣΙΚΑΣΑΣΑΗ ΑΟΡΣΙΚΗ ΒΑΛΒΙΔΑ αντιμετώπιση επιπλοκών ΠΕΣΡΟ. ΔΑΡΔΑ, MD, FESC IICE 2012

ΔΙΑΔΕΡΜΙΚΗ ΑΝΣΙΚΑΣΑΣΑΗ ΑΟΡΣΙΚΗ ΒΑΛΒΙΔΑ αντιμετώπιση επιπλοκών ΠΕΣΡΟ. ΔΑΡΔΑ, MD, FESC IICE 2012 ΔΙΑΔΕΡΜΙΚΗ ΑΝΣΙΚΑΣΑΣΑΗ ΑΟΡΣΙΚΗ ΒΑΛΒΙΔΑ αντιμετώπιση επιπλοκών ΠΕΣΡΟ. ΔΑΡΔΑ, MD, FESC IICE 2012 TAVR Technologies Current Generation Devices ~ 50,000 patients treated thru 2011 in > 500 interventional centers

More information

TAVI Implantation: Rapid Pacing, Pre and Post Dilatation

TAVI Implantation: Rapid Pacing, Pre and Post Dilatation TAVI Summit 2012 Seoul, September 9, 2012 TAVI Implantation: Rapid Pacing, Pre and Post Dilatation Eberhard Grube, MD, FACC, FSCAI Medizinische i i Klinik ik und Polikinik II, University i Hospital Bonn,

More information

ECG Interactive Session

ECG Interactive Session SA HEART 2018 PRE-CONGRESS WORKSHOP 4 OCTOBER 2018 ECG Interactive Session Ashley Chin Cardiologist/Electrophysiologist University of Cape Town Groote Schuur Hospital ECG 1 Which ONE of the following is

More information

Comments restricted to Sapien and Corevalve 9/12/2016. Disclosures: Core Lab contracts with Edwards Lifesciences, Middlepeak, Medtronic

Comments restricted to Sapien and Corevalve 9/12/2016. Disclosures: Core Lab contracts with Edwards Lifesciences, Middlepeak, Medtronic Para-ValvularRegurgitation post TAVR: Predict, Prevent, Quantitate, Manage Linda D. Gillam, MD, MPH, FACC, FASE Chair, Department of Cardiovascular Medicine Morristown Medical Center/Atlantic Health System

More information

Transcatheter aortic valve implantation for severe aortic valve stenosis with the ACURATE neo2 valve system: 30-day safety and performance outcomes

Transcatheter aortic valve implantation for severe aortic valve stenosis with the ACURATE neo2 valve system: 30-day safety and performance outcomes All cited trademarks are the property of their respective owners. CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings and instructions

More information

Arrhythmia Mechanisms

Arrhythmia Mechanisms Mechanisms of Heart Block after Transcatheter Aortic Valve Replacement Cardiac Anatomy, Clinical Predictors and Mechanical Factors that Contribute to Permanent Pacemaker Implantation Mark Young Lee, Srinath

More information

Strokes After TAVR Reasons for Declining Frequency

Strokes After TAVR Reasons for Declining Frequency Strokes After TAVR Reasons for Declining Frequency Samir Kapadia, MD Professor of Medicine Director, Cardiac Catheterization Laboratory Cleveland Clinic Disclosure NONE Second Generation Valves Newer

More information

Post-TAVI Cerebral Embolisms and Potential Protection Means

Post-TAVI Cerebral Embolisms and Potential Protection Means Post-TAVI Cerebral Embolisms and Potential Protection Means Josep Rodés-Cabau, MD Quebec Heart & Lung Institute, Laval University Quebec City, Quebec, Canada EBR Marseille, May 2012 Conflict of Interest

More information

How Do I Evaluate a Patient Being Considered for TAVR? Sunday, February 14, :00 11:25 PM 25 min

How Do I Evaluate a Patient Being Considered for TAVR? Sunday, February 14, :00 11:25 PM 25 min 2016 ASE State of the Art Echocardiography Course Tucson, AZ How Do I Evaluate a Patient Being Considered for TAVR? Sunday, February 14, 2016 11:00 11:25 PM 25 min 1 M U H A M E D S A R I Ć, M D, P H D

More information

Patient with low-flow low-gradient aortic stenosis and ischemic cardiomyopathy TAVR and possibly percutaneous revascularization

Patient with low-flow low-gradient aortic stenosis and ischemic cardiomyopathy TAVR and possibly percutaneous revascularization Patient with low-flow low-gradient aortic stenosis and ischemic cardiomyopathy TAVR and possibly percutaneous revascularization + K Spargias, MD, PhD THV Director Hygeia Hospital Disclosures - Proctor

More information

DICE Session. The endocarditis team. Bernard Iung Bichat Hospital, Paris Diderot University Paris, France

DICE Session. The endocarditis team. Bernard Iung Bichat Hospital, Paris Diderot University Paris, France DICE Session. The endocarditis team Bernard Iung Bichat Hospital, Paris Diderot University Paris, France Faculty disclosure First name - last name I disclose the following financial relationships: Consultant

More information

Percutaneous Management of Severe AS in Octagenarians. Phillip Matsis FRACP FCSANZ Interventional Cardiologist Wakefield Heart Centre Wellington

Percutaneous Management of Severe AS in Octagenarians. Phillip Matsis FRACP FCSANZ Interventional Cardiologist Wakefield Heart Centre Wellington Percutaneous Management of Severe AS in Octagenarians Phillip Matsis FRACP FCSANZ Interventional Cardiologist Wakefield Heart Centre Wellington May 2017 Outline Aetiology of AS Natural History of AS Assessment

More information

Valvular Heart Disease and TAVR Grand Rounds, Cedar Sinai April 11, 2013.

Valvular Heart Disease and TAVR Grand Rounds, Cedar Sinai April 11, 2013. Valvular Heart Disease and TAVR Grand Rounds, Cedar Sinai April 11, 2013. Renu Virmani, MD CVPath Institute Inc. Gaithersburg, MD Background TAVR First aortic valve replacement 1960 (Harken DE et al J.

More information

Aortic Stenosis: Background

Aortic Stenosis: Background Transcatheter Aortic Valve Replacement in Low Surgical Risk Patients Barry George, MD The Ohio State University Structural Heart Disease Course May 19 th, 2017 Aortic Stenosis: Background Severe Symptomatic

More information

Aortic valve calcium load before TAVI: Is it important?

Aortic valve calcium load before TAVI: Is it important? Research Highlight Aortic valve calcium load before TAVI: Is it important? Martin Haensig 1, Ardawan Julian Rastan 2 1 Department of Cardiac Surgery, Heart Center, University of Leipzig, Germany; 2 Department

More information

David Dexter MD FACS Sentara Vascular Specialists Assistant Professor of Surgery EVMS. Peripheral Complications of TAVR

David Dexter MD FACS Sentara Vascular Specialists Assistant Professor of Surgery EVMS. Peripheral Complications of TAVR David Dexter MD FACS Sentara Vascular Specialists Assistant Professor of Surgery EVMS Peripheral Complications of TAVR TAVR Complications Reported Complications Rates range from 8% to 15% Predictors of

More information

Mitral Valve prolapse: What s new? Which indications of early surgery? Input of new 2017 ESC/EACTS guidelines. Christophe Tribouilloy Amiens, France

Mitral Valve prolapse: What s new? Which indications of early surgery? Input of new 2017 ESC/EACTS guidelines. Christophe Tribouilloy Amiens, France Mitral Valve prolapse: What s new? Which indications of early surgery? Input of new 2017 ESC/EACTS guidelines Christophe Tribouilloy Amiens, France I have no financial relationships to disclose related

More information

Paravalvular Regurgitation is a Risk Factor Following TAVI

Paravalvular Regurgitation is a Risk Factor Following TAVI Paravalvular Regurgitation is a Risk Factor Following TAVI Philippe Pibarot, DVM, PhD, FACC, FESC, FASE Canada Research Chair in Valvular Heart Disease INSTITUT UNIVERSITAIRE DE CARDIOLOGIE ET DE PNEUMOLOGIE

More information

Aortic Stenosis in the Elderly: Difficulties for the Clinician. Are Symptoms Due to Aortic Stenosis?

Aortic Stenosis in the Elderly: Difficulties for the Clinician. Are Symptoms Due to Aortic Stenosis? Aortic Stenosis in the Elderly: Difficulties for the Clinician Are Symptoms Due to Aortic Stenosis? Raphael Rosenhek Department of Cardiology Medical University of Vienna No disclosure European Society

More information

Indication, Timing, Assessment and Update on TAVI

Indication, Timing, Assessment and Update on TAVI Indication, Timing, Assessment and Update on TAVI Swedish Heart and Vascular Institute Ming Zhang MD PhD Interventional Cardiology Structure Heart Disease Conflict of Interest None Starr- Edwards Mechanical

More information

TAVI EN INSUFICIENCIA AORTICA

TAVI EN INSUFICIENCIA AORTICA TAVI EN INSUFICIENCIA AORTICA Cesar Moris Profesor Cardiología Director Departamento del Corazón Hospital Universitario Central de Asturias Universidad de Oviedo OVIEDO -- ESPAÑA CONFLICTO DE INTERESES

More information

Aortic Valve Practice Guidelines: What Has Changed and What You Need to Know

Aortic Valve Practice Guidelines: What Has Changed and What You Need to Know Aortic Valve Practice Guidelines: What Has Changed and What You Need to Know James F. Burke, MD Program Director Cardiovascular Disease Fellowship Lankenau Medical Center Disclosure Dr. Burke has no conflicts

More information

Embolic Protection Devices for Transcatheter Aortic Valve Replacement

Embolic Protection Devices for Transcatheter Aortic Valve Replacement Embolic Protection Devices for Transcatheter Aortic Valve Replacement James M. McCabe, MD Medical Director, Cardiac Cath Lab University of Washington Seattle, WA Disclosures Proctoring and honoraria for

More information

Percutaneous Treatment of Valvular Heart Diseases: Lessons and Perspectives. Bernard Iung Bichat Hospital, Paris

Percutaneous Treatment of Valvular Heart Diseases: Lessons and Perspectives. Bernard Iung Bichat Hospital, Paris Percutaneous Treatment of Valvular Heart Diseases: Lessons and Perspectives Bernard Iung Bichat Hospital, Paris Euro Heart Survey on Valvular Diseases 3547 Patients with Native Valve Disease n= 1250 1000

More information

Aortic Stenosis: Interventional Choice for a 70-year old- SAVR, TAVR or BAV? Interventional Choice for a 90-year old- SAVR, TAVR or BAV?

Aortic Stenosis: Interventional Choice for a 70-year old- SAVR, TAVR or BAV? Interventional Choice for a 90-year old- SAVR, TAVR or BAV? Aortic Stenosis: Interventional Choice for a 70-year old- SAVR, TAVR or BAV? Interventional Choice for a 90-year old- SAVR, TAVR or BAV? Samin K Sharma, MD, FACC, FSCAI Director Clinical & Interventional

More information

TAVI- Is Stroke Risk the Achilles Heel of Percutaneous Aortic Valve Repair?

TAVI- Is Stroke Risk the Achilles Heel of Percutaneous Aortic Valve Repair? TAVI- Is Stroke Risk the Achilles Heel of Percutaneous Aortic Valve Repair? Elaine E. Tseng, MD and Marlene Grenon, MD Department of Surgery Divisions of Adult Cardiothoracic and Vascular and Endovascular

More information